Infection-related mortality in children with malignancy in England and Wales, 2003-2005

Pediatric Blood and Cancer

Volumn 53, Issue 3, 2009, Pages 371-374

  Bate, Jessica ^a   Ladhani, Shamez ^a,b   Sharland, Mike ^a   Chisholm, Julia ^c   Lamagni, Theresa ^b   Ramsay, Mary ^b   Johnson, Alan ^b   Pebody, Richard ^b  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^b PUBLIC HEALTH ENGLAND   (United Kingdom)

^c GREAT ORMOND STREET HOSPITAL   (United Kingdom)

Author keywords

England; Infection; Malignancy; Mortality; Paediatric; Wales

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADENOVIRUS; ADOLESCENT; AGE DISTRIBUTION; ARTICLE; ASPERGILLUS; BONE TUMOR; BRAIN INFECTION; BRAIN TUMOR; BRONCHIOLITIS; BURKITT LYMPHOMA; CAUSE OF DEATH; CHILD; CHRONIC MYELOID LEUKEMIA; DEATH CERTIFICATE; DOWN SYNDROME; ENDOCARDITIS; ESCHERICHIA COLI; FEMALE; GRAM NEGATIVE BACTERIUM; HEMATOLOGIC MALIGNANCY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HODGKIN DISEASE; HUMAN; INFECTION; INTERNATIONAL CLASSIFICATION OF DISEASES; MAJOR CLINICAL STUDY; MALE; MORTALITY; MYCOSIS; NEPHROBLASTOMA; NEUROBLASTOMA; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; RELAPSE; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; SEPTICEMIA; SOFT TISSUE TUMOR; SOLID TUMOR; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE; UNITED KINGDOM;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; ENGLAND; HUMANS; INFANT; INFANT, NEWBORN; INFECTION; MALE; NEOPLASMS; TIME FACTORS; WALES;

EID: 67651230909     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.22057     Document Type: Article

References (21)

1. Stiller C. A childhood cancer in Britain: Incidence. Survival: Mortality Oxford University Press; 2007.
2. Stiller CA. Centralised treatment, entry to trials and survival. Br J Cancer 1994;70:352-362.
3. Wheeler K, Chessells JM, Bailey CC, et al. Treatment related deaths during induction and in first remission in acute lymphoblastic leukaemia:MRCUKALL X. Arch Dis Child 1996;74:101-107. (Pubitemid 26057690)
4. Bodey GP, Buckley M, Sathe YS. et al. Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia. Ann Intern Med 1966;64:328-340.
5. Office for National Statistics. Mortality Statistics (Cause): Series DH2. No.30-32. 2003-2005; Table 2.2. C0-96 ICD-10.
6. Children's Cancer and Leukaemia Group: Scientific Report 2008. Section 2.
7. Hann I, Viscoli C, Paesmans M, et al. A comparison of outcome from febrile neutropenic episodes in children compared with adults: Results from four EORTC studies. International Antimicrobial Therapy Cooperative Group (IATCG) of the European Organization for Research and Treatment of Cancer (EORTC). Br J Haematol 1997;99:580-588.
8. Basu SK, Fernandez ID, Fisher SG, et al. Length of stay and mortality associated with febrile neutropenia among children with cancer. J Clin Oncol 2005;23:7958-7966. (Pubitemid 46657396)
9. Laws HJ, Schneider DT, Janssen G, et al. Trends in infections in children with malignant disease in 2000: Comparison of data of 1980/81. Pediatr Hematol Oncol 2007;24:343-354.
10. Viscoli C, Castagnola E, Giacchino M, et al. Bloodstream infections in children with cancer: A multicentre surveillance study of the Italian Association of Paediatric Haematology and Oncology. Supportive Therapy Group-Infectious Diseases Section. Eur J Cancer 1999;35:770-774.
11. Pound CM, Johnston DL, Armstrong R, et al. The morbidity and mortality of pediatric oncology patients presenting to the intensive care unit with septic shock. Pediatr Blood Cancer 2008;51:584-588.
12. Fiser RT, West NK, Bush AJ, et al. Outcome of severe sepsis in pediatric oncology patients. Pediatr Crit Care Med 2005;6:531-536.
13. Dommett R, Sharland M, Freeman S, et al. Prospective audit of a low risk management strategy in febrile neutropenia (FN) - A Thames Paediatric Oncology Centre (TPOC) study. Pediatr Blood Cancer 2005;45:418.
14. Grigull L, Beier R, Schrauder A, et al. Invasive fungal infections are responsible for one-fifth of the infectious deaths in children with ALL. Mycoses 2003;46:441-446. (Pubitemid 38005338)
15. Zaoutis TE, Heydon K, Chu JH, et al. Epidemiology, outcomes, and costs of invasive aspergillosis in immunocompromised children in the United States, 2000. Pediatrics 2006;117:711-716.
16. Kuhlman JE, Fishman EK, Burch PA, et al. Invasive pulmonary aspergillosis in acute leukemia. The contribution of CT to early diagnosis and aggressive management. Chest 1987;92:95-99.
17. Klont RR, Meis JF, Verweij PE. Critical assessment of issues in the diagnosis of invasive aspergillosis. Clin Microbiol Infect 2001;7:32-37. (Pubitemid 34960250)
18. Hovi L, Saarinen-Pihkala UM, Vettenranta K, et al. Invasive fungal infections in pediatric bone marrow transplant recipients: single center experience of 10 years. Bone Marrow Transplant 2000;26:999-1004. (Pubitemid 30821610)
19. Evans PM, Alberman E. Certified cause of death in children and young adults with cerebral palsy. Arch Dis Child 1991;66:325-329.
20. Millar MR, Johnson G, Wilks M, et al. Molecular diagnosis of vascular access device-associated infection in children being treated for cancer or leukaemia. Clin Microbiol Infect 2008;14:213-220. (Pubitemid 351201011)
21. Hargrave DR, Hann II, Richards SM, et al. Progressive reduction in treatment-related deaths in Medical Research Council childhood lymphoblastic leukaemia trials from 1980 to 1997 (UKALL VIII, X and XI). Br J Haematol 2001;112:293-299.